Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to 2.04%.

  • Harvard Bioscience's Return on Capital Employed fell 19800.0% to 2.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.04%, marking a year-over-year decrease of 19800.0%. This contributed to the annual value of 0.08% for FY2024, which is 1000.0% down from last year.
  • Per Harvard Bioscience's latest filing, its Return on Capital Employed stood at 2.04% for Q3 2025, which was down 19800.0% from 2.12% recorded in Q2 2025.
  • Over the past 5 years, Harvard Bioscience's Return on Capital Employed peaked at 0.02% during Q4 2023, and registered a low of 2.12% during Q2 2025.
  • In the last 5 years, Harvard Bioscience's Return on Capital Employed had a median value of 0.02% in 2024 and averaged 0.29%.
  • Per our database at Business Quant, Harvard Bioscience's Return on Capital Employed soared by 700bps in 2023 and then plummeted by -20700bps in 2025.
  • Quarter analysis of 5 years shows Harvard Bioscience's Return on Capital Employed stood at 0.02% in 2021, then crashed by -462bps to 0.06% in 2022, then soared by 130bps to 0.02% in 2023, then plummeted by -596bps to 0.08% in 2024, then crashed by -2330bps to 2.04% in 2025.
  • Its Return on Capital Employed stands at 2.04% for Q3 2025, versus 2.12% for Q2 2025 and 1.13% for Q1 2025.